Miguel C. Seabra

Miguel C Seabra, MD, PhD, is a leading researcher in the field of cellular and molecular medicine. MS holds a PhD from University of Texas Southwestern Medical Center (1992), where he was an Assistant Professor, before moving to the Faculty of Medicine, Imperial College London where he became Full Professor and head of Section until 2007. MS is now Full Professor at the Medical School of the Universidade Nova de Lisboa, Portugal, where he coordinates research in Cellular and Molecular Medicine and holds several chairs. MS has a long track record in vision sciences and has been the leader of a pioneering clinical trial of retinal gene therapy. Moreover, MS have provided remarkable contributions for the elucidation of the cellular and molecular mechanisms underlying Choroideremia, AMD and DR (Diabetic Retinopathy). MS was president of Fundação para a Ciência e a Tecnologia (FCT) from 2012 to 2015, the portuguese public funding agency for science and research in Portugal.